SERMs in the prevention and treatment of postmenopausal osteoporosis: an update. - Wikidata - awgldk - TriplyDB

SERMs in the prevention and treatment of postmenopausal osteoporosis: an update.

SERMs in the prevention and treatment of postmenopausal osteoporosis: an update.

http://www.wikidata.org/entity/Q35028647

about

Endometrial Cancer-Associated FGF18 Expression Is Reduced by Bazedoxifene in Human Endometrial Stromal Cells In Vitro and in Murine Endometrium.Effects of estrogen receptor modulators on cytoskeletal proteins in the central nervous system.

P2860

Q41640781-55FB8893-10E7-498B-9565-A755754624DD Q42361824-1328354B-F52D-4477-BE15-0C8F40273D1F

P2860

SERMs in the prevention and treatment of postmenopausal osteoporosis: an update.

http://www.wikidata.org/entity/Q35028647

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

SERMs in the prevention and treatment of postmenopausal osteoporosis: an update.

@ast

SERMs in the prevention and treatment of postmenopausal osteoporosis: an update.

@en

type

label

SERMs in the prevention and treatment of postmenopausal osteoporosis: an update.

@ast

SERMs in the prevention and treatment of postmenopausal osteoporosis: an update.

@en

prefLabel

SERMs in the prevention and treatment of postmenopausal osteoporosis: an update.

@ast

SERMs in the prevention and treatment of postmenopausal osteoporosis: an update.

@en

P1433

Q35028647-398C89E6-1C73-49F3-811D-8E028AF35780

P1476

Q35028647-FECA40E5-4CC1-4ED8-8B6C-DF94F604B0C2

P2093

Q35028647-32FF9143-EF4D-442F-BA7E-06826806BA49

Q35028647-7F0BA66F-1FDF-4E3A-A277-6ABCCBEF376D

P2860

Q35028647-0AF43556-3723-4FAE-9D6E-A4ECF00B3757

Q35028647-11754565-2CC6-478D-AC9B-F68EAC5E1784

Q35028647-28D76778-0E5D-4C92-BA99-955BF11E6A15

Q35028647-29FE8F57-61CB-4D46-8C03-66DB09EA643A

Q35028647-2A778EA3-151F-4A7F-AEB3-83C15D8F806B

Q35028647-3A3272D5-65F6-4956-8249-90636EA0922A

Q35028647-3B025DA8-7802-47BB-BE0F-A483D3FFAE4D

Q35028647-42173AE1-F3D1-4814-8831-7BAB2EBA6A51

Q35028647-4F22673A-7F32-460E-BE15-E953BD248E8D

Q35028647-5AA35DF7-6B15-4A4B-9D51-4CB7C5709BC1

P304

Q35028647-E1C54D35-5AC4-466A-BF09-608ACF190E34

P31

Q35028647-8172BA06-8155-427A-9F0A-63AAFC95BB16

P356

Q35028647-66A799A0-9655-4C38-80E2-FFE247D98C85

P433

Q35028647-CE379672-30A4-457A-AFB5-31E5DA287674

P478

Q35028647-FA4D4836-E071-48A7-A8EA-F651B1589E2B

P50

Q35028647-3301804D-BAAA-494D-B6A5-A197D88DC450

P577

Q35028647-61764913-2DCA-4784-B570-F6168FAD16DD

P698

Q35028647-9A6539EF-90B9-4B54-ACA5-D8CA5F95C595

P921

Q35028647-6D3B8750-6506-4FF6-BE1B-3A4EE3907CB0

P932

Q35028647-61AB01A9-68EB-4D28-AAC1-B6356938E35D

P356

S0004-27302010000200016

P1433

Arquivos Brasileiros de Endocrinologia e Metabologia

P1476

SERMs in the prevention and treatment of postmenopausal osteoporosis: an update

@en

P2093

Hugh S Taylor

http://www.w3.org/2001/XMLSchema#string

Jaime Kulak Júnior

http://www.w3.org/2001/XMLSchema#string

P2860

Estradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors alpha and beta

Coregulator function: a key to understanding tissue specificity of selective receptor modulators

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial

Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer

Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer

Occurrence of stroke with tamoxifen in NSABP B-24

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

Selective estrogen-receptor modulators -- mechanisms of action and application to clinical practice.

Effects of ospemifene, a novel SERM, on hormones, genital tract, climacteric symptoms, and quality of life in postmenopausal women: a double-blind, randomized trial.

Selective estrogen receptor modulation and reduction in risk of breast cancer, osteoporosis, and coronary heart disease.

P304

200-205

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1590/S0004-27302010000200016

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20485909

http://www.w3.org/2001/XMLSchema#string

P921

P932

3109295

http://www.w3.org/2001/XMLSchema#string